Böblingen, February 20, 2025 – The family-owned company Wörwag Pharma achieved an organic revenue growth of 10.5% in 2024, significantly outperforming the market across all 35 countries where it operates. The company generated a revenue of €331 million with around 1,500 dedicated employees worldwide.